Could smarter trial design unlock better dementia treatments?
NCT ID NCT05592678
First seen May 01, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study explores better methods for running clinical trials in dementia and cognitive decline. Researchers will use a new measurement called 'δ' that combines thinking ability and daily function, along with blood protein levels, to see if they can predict who will respond to the Alzheimer's drug donepezil. About 200 older adults with mild cognitive impairment or Alzheimer's and their caregivers will participate. The goal is not to test a new treatment, but to improve how future trials measure success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Univeristy of Texas Health Science Center at San Antonio (UTHSCSA)
RECRUITINGSan Antonio, Texas, 78229-3900, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.